🇺🇸 FDA
Pipeline program

68Ga-AAZTA-NI-093

FAHFJ-68Ga-AAZTA-NI-093

Phase 1 small_molecule active

Quick answer

68Ga-AAZTA-NI-093 for Prostate Cancer (Adenocarcinoma) is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Prostate Cancer (Adenocarcinoma)
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials